Published in J Clin Microbiol on February 01, 1979
Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses. J Clin Microbiol (1979) 3.05
Enzyme immunoassay for direct detection of influenza type A and adenovirus antigens in clinical specimens. J Clin Microbiol (1982) 1.71
Spatial dynamics of human-origin H1 influenza A virus in North American swine. PLoS Pathog (2011) 1.68
Alternative cell line for virus isolation. J Clin Microbiol (1986) 1.65
Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus. J Exp Med (1981) 1.64
Retracted Burden of influenza in healthy children and their households. Arch Dis Child (2004) 1.63
Live Animal Markets in Minnesota: A Potential Source for Emergence of Novel Influenza A Viruses and Interspecies Transmission. Clin Infect Dis (2015) 1.60
MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells. J Clin Microbiol (2008) 1.59
Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment. Antimicrob Agents Chemother (2013) 1.39
Detection of influenza virus by centrifugal inoculation of MDCK cells and staining with monoclonal antibodies. J Clin Microbiol (1989) 1.33
Comparison of Madin-Darby canine kidney cells (MDCK) with a green monkey continuous cell line (Vero) and human lung embryonated cells (MRC-5) in the isolation of influenza A virus from nasopharyngeal aspirates by shell vial culture. J Clin Microbiol (1997) 1.30
Comparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passage. PLoS One (2013) 1.23
Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory. Infect Immun (1983) 1.14
Vaccination of influenza a virus decreases transmission rates in pigs. Vet Res (2011) 1.12
Sensitivity of oral fluids for detecting influenza A virus in populations of vaccinated and non-vaccinated pigs. Influenza Other Respir Viruses (2011) 1.11
Physical and chemical methods for enhancing rapid detection of viruses and other agents. Clin Microbiol Rev (1993) 1.05
Relative efficacy of embryonated eggs and cell culture for isolation of contemporary influenza viruses. J Clin Microbiol (1981) 1.03
Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas. Infect Immun (1983) 0.99
Influenza A virus isolation, culture and identification. Nat Protoc (2014) 0.97
The impact of maternally derived immunity on influenza A virus transmission in neonatal pig populations. Vaccine (2012) 0.96
Sensitivity of NCI-H292 human lung mucoepidermoid cells for respiratory and other human viruses. J Clin Microbiol (1993) 0.94
Indirect Transmission of Influenza A Virus between Pig Populations under Two Different Biosecurity Settings. PLoS One (2013) 0.92
Cell-mediated immune response of human lymphocytes to influenza A/USSR (H1N1) virus infection. Infect Immun (1980) 0.86
Efficacy of swine influenza A virus vaccines against an H3N2 virus variant. Can J Vet Res (2007) 0.86
Recent contributions of molecular biology to the clinical virology of myxoviruses. Yale J Biol Med (1980) 0.85
Human malignant melanoma cell line (HMV-II) for isolation of influenza C and parainfluenza viruses. J Clin Microbiol (1990) 0.82
Association between Influenza A Virus Infection and Pigs Subpopulations in Endemically Infected Breeding Herds. PLoS One (2015) 0.80
In vivo evaluation of vaccine efficacy against challenge with a contemporary field isolate from the α cluster of H1N1 swine influenza virus. Can J Vet Res (2013) 0.79
Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks. Crit Care (2010) 0.78
Exploring variation in the d(N)/d(S) ratio among sites and lineages using mutational mappings: applications to the influenza virus. J Mol Evol (2007) 0.78
Selected laboratory aspects of influenza surveillance. Yale J Biol Med (1983) 0.76
Genome plasticity of triple-reassortant H1N1 influenza A virus during infection of vaccinated pigs. J Gen Virol (2015) 0.75
Complete Genome Sequencing of Influenza A Viruses within Swine Farrow-to-Wean Farms Reveals the Emergence, Persistence, and Subsidence of Diverse Viral Genotypes. J Virol (2017) 0.75
Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med Microbiol Immunol (1975) 4.89
Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci U S A (1966) 3.56
Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl Microbiol (1968) 3.04
Characterization of an established line of canine kidney cells (MDCK). Proc Soc Exp Biol Med (1966) 2.66
The structure of influenza viruses. IV. Chemical studies of the host antigen. Virology (1966) 2.31
Permanent canine kidney (MDCK) cells for isolation and plaque assay of influenza B viruses. Med Microbiol Immunol (1975) 1.89
The influenza virus haemagglutinnation inhibition by antibody to host material. Acta Pathol Microbiol Scand (1963) 1.48
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med (2000) 8.46
Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr (2000) 4.08
Primary respiratory syncytial virus infection in mice. J Med Virol (1988) 3.77
Molecular diversity of the NMDA receptor channel. Nature (1992) 3.76
Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest (1991) 3.71
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol (1971) 3.33
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis (1992) 3.07
Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun (1982) 2.61
A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis (1994) 2.52
Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children < 5 years old. J Infect Dis (1997) 2.12
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol (1986) 2.09
Comparison of competitive and indirect enzyme-linked immunosorbent assays for detection of bluetongue virus antibodies in serum and whole blood. J Clin Microbiol (1987) 2.07
Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol (1980) 1.97
Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis (1986) 1.97
IV. The Relations of the Gross Anatomy of the Vermiform Appendix to some Features of the Clinical History of Appendicitis. Ann Surg (1893) 1.95
Temperature-sensitive mutants of respiratory syncytial virus. J Virol (1969) 1.94
Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J (2001) 1.90
Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol (1985) 1.88
Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J Infect Dis (1997) 1.86
The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr (2000) 1.85
Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis (1994) 1.78
Adenovirus infections in young children. Pediatrics (1985) 1.76
Changing presentation of herpes simplex virus infection in neonates. J Infect Dis (1988) 1.76
A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J Infect Dis (1995) 1.68
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. J Infect Dis (1993) 1.67
Cytomegalovirus pneumonia in two infants recently adopted from China. Clin Infect Dis (1999) 1.65
The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J (1999) 1.64
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis (1998) 1.64
Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infect Immun (1982) 1.61
Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis (1982) 1.61
Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children. J Clin Microbiol (1985) 1.59
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis (1988) 1.52
Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials. Pediatrics (1997) 1.51
Temperature-sensitive mutants of respiratory syncytial virus: in-vivo studies in hamsters. J Infect Dis (1970) 1.51
Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults. J Infect Dis (1980) 1.47
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. J Infect Dis (1998) 1.47
Safety and antigenicity of influenza A/Hong Kong/68-ts-1 (E) (H3N2). J Pediatr (1975) 1.45
Candidate AIDS vaccines. N Engl J Med (1995) 1.41
Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. J Infect Dis (1983) 1.41
Reinfection of mice with respiratory syncytial virus. J Med Virol (1991) 1.39
Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. Vaccine (1999) 1.37
Genetic studies of respiratory syncytial virus temperature-sensitive mutants. Arch Gesamte Virusforsch (1973) 1.36
A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J Infect Dis (1995) 1.36
Selective expression of the glutamate receptor channel delta 2 subunit in cerebellar Purkinje cells. Biochem Biophys Res Commun (1993) 1.34
Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. N Engl J Med (1977) 1.32
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants. J Pediatr (1976) 1.31
Growth of influenza A virus in primary, differentiated epithelial cells derived from adenoids. J Virol (1996) 1.29
Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. J Infect Dis (1977) 1.26
Chromosome complement of the fungal plant pathogen Fusarium graminearum based on genetic and physical mapping and cytological observations. Genetics (2005) 1.26
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. J Infect Dis (1992) 1.25
Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. J Clin Microbiol (1986) 1.22
Respiratory syncytial virus infection in anti-mu-treated mice. J Virol (1991) 1.20
Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus. Infect Immun (1980) 1.19
Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J Infect Dis (1996) 1.19
Electron microscopic studies of respiratory syncytial temperature-sensitive mutants. Arch Gesamte Virusforsch (1973) 1.16
Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines. Rev Infect Dis (1981) 1.15
Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory. Infect Immun (1983) 1.14
Age-related response to two Haemophilus influenzae type b vaccines. J Pediatr (1982) 1.14
Immune correlates of protection against influenza in the human challenge model. Dev Biol (Basel) (2003) 1.13
Role of respiratory tract proteases in infectivity of influenza A virus. J Infect Dis (1987) 1.13
Evaluation of a temperature-sensitive mutant of respiratory syncytial virus in adults. J Infect Dis (1971) 1.12
Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis. J Infect Dis (1976) 1.12
A colorimetric microtiter plate PCR system detects respiratory syncytial virus in nasal aspirates and discriminates subtypes A and B. Diagn Microbiol Infect Dis (1999) 1.11
A comparison of five serological tests for bovine brucellosis. Can J Vet Res (1986) 1.10
[Pharmacokinetic and clinical studies of S-1108 in the pediatric field. Pediatric Study Group of S-1108]. Jpn J Antibiot (1995) 1.08
Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults. Vaccine (2000) 1.07
Aprotinin and similar protease inhibitors as drugs against influenza. Antiviral Res (2011) 1.05
Colonic carcinoma resembling submucosal tumor: report of a case and review of the literature. Int J Gastrointest Cancer (2005) 1.04
Lack of comparability between commonly used serological assays of immune response to Haemophilus influenzae vaccine. J Infect Dis (1987) 1.04
Application of a timing protocol to the reduction of inter-plate variability in the indirect enzyme immunoassay for detection of anti-Brucella antibody. J Immunoassay (1985) 1.04
Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants. Vaccine (1999) 1.04
Eustachian tube histopathology during experimental influenza A virus infection in the chinchilla. Ann Otol Rhinol Laryngol (1987) 1.03
Functional expression from cloned cDNAs of glutamate receptor species responsive to kainate and quisqualate. FEBS Lett (1990) 1.03
III. Ligation of the External Carotid Artery: With Remarks on the History of the Operation. Ann Surg (1887) 1.03
An outbreak of airborne nosocomial varicella. Pediatrics (1982) 1.03
Ureaplasma urealyticum polyarthritis in agammaglobulinemia. Pediatr Infect Dis (1986) 1.02
A critical study of the measurement and calibration of circular dichroism. Anal Biochem (1977) 1.02
Development and evaluation of an indirect enzyme immunoassay for detection of porcine antibodies to pseudorabies virus. Can J Vet Res (1986) 1.01
Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response. Vaccine (1997) 1.01
A review of enzyme immunoassay for detection of antibody to Brucella abortus in cattle. Vet Immunol Immunopathol (1988) 1.01
Management of genital herpes simplex virus infection occurring during pregnancy. Am J Obstet Gynecol (1981) 1.01
Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage. Rev Infect Dis (1981) 1.00
Clinical implications of preseptal (periorbital) cellulitis in childhood. Pediatrics (1978) 1.00
The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. FEMS Immunol Med Microbiol (1999) 0.99
Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas. Infect Immun (1983) 0.99
Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation. Clin Diagn Lab Immunol (1999) 0.98
Antibody-dependent cell-mediated cytotoxicity against cells infected with respiratory syncytial virus: characterization of in vitro and in vivo properties. J Immunol (1979) 0.98
Complications of occult pneumococcal bacteremia in children. J Pediatr (1974) 0.98
The pharmacokinetics and efficacy of an aminoglycoside administered into the cerebral ventricles in neonates: implications for further evaluation of this route of therapy in meningitis. J Infect Dis (1981) 0.98
Optimization and standardization of an enzyme-linked immunosorbent assay protocol for serodiagnosis of Actinobacillus pleuropneumoniae serotype 5. J Clin Microbiol (1992) 0.97
Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils. Am J Pathol (2000) 0.97
Diatoms and the ecological conditions of their growth in sea ice in the arctic ocean. Science (1966) 0.97
A gastric hyperplastic polyp observed endoscopically before and after autoamputation. Endoscopy (2003) 0.97
Distribution of lymphoid leukosis virus and p27 group-specific antigen in tissues from laying hens. Avian Dis (1984) 0.96
Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination. Dev Biol Stand (1978) 0.96